Biotech News

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Aethlon Medical (AEMD)Aethlon Medical2026-06-25 13:46 ESTClinical readout

AEMD (AEMD) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is aemd.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

AEMDAethlon Medical2026-06-25 13:46 EST

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

View all latest news

Aethlon Medical

Aethlon Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.

Recent company news

AEMDAethlon Medical2026-06-26 08:28 EST

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

AEMDAethlon Medical2026-06-26 08:28 EST

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

AEMDAethlon Medical2026-06-26 08:28 EST

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness

AEMDAethlon Medical2026-06-26 08:28 EST

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

AEMDAethlon Medical2026-06-26 08:28 EST

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States